TDM is most valuable for drugs with which characteristics?

TDM is most valuable for drugs with which characteristics?

• A. Narrow therapeutic index and high interpatient variability
• B. Wide therapeutic index and low variability
• C. Predictable pharmacokinetics and low toxicity
• D. No need for monitoring under any circumstances

Answer: (A)

Therapeutic drug monitoring is most valuable for drugs where small changes in drug level can mean the difference between no effect and toxicity, and where patients differ a lot in how they process the drug. When the therapeutic index is narrow, the range of concentrations that are effective without being harmful is small. If interpatient variability is high, the same dose can produce very different blood levels in different people. Measuring the actual drug level in the patient and adjusting the dose helps keep the concentration in that safe-and-effective window for each individual. By contrast, drugs with a wide therapeutic index tolerate a broader range of concentrations without safety or efficacy issues, and low variability in how patients process them makes their dosing more predictable. For those drugs, routine monitoring isn’t as critical. And saying there’s no need for monitoring under any circumstances isn’t accurate because many drugs still benefit from monitoring in certain populations or clinical situations to ensure safety and effectiveness.

Therapeutic drug monitoring is most valuable for drugs where small changes in drug level can mean the difference between no effect and toxicity, and where patients differ a lot in how they process the drug. When the therapeutic index is narrow, the range of concentrations that are effective without being harmful is small. If interpatient variability is high, the same dose can produce very different blood levels in different people. Measuring the actual drug level in the patient and adjusting the dose helps keep the concentration in that safe-and-effective window for each individual.

By contrast, drugs with a wide therapeutic index tolerate a broader range of concentrations without safety or efficacy issues, and low variability in how patients process them makes their dosing more predictable. For those drugs, routine monitoring isn’t as critical. And saying there’s no need for monitoring under any circumstances isn’t accurate because many drugs still benefit from monitoring in certain populations or clinical situations to ensure safety and effectiveness.